+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Basal Cell Carcinoma Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017-2025

  • ID: 4852056
  • Report
  • February 2018
  • Region: Global
  • 165 pages
  • Transparency Market Research
1 of 2

Basal Cell Carcinoma Treatment Market: Overview

This report on the global basal cell carcinoma treatment market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also provide insights into the key trends of the basal cell carcinoma treatment market such as augmentation in clinical trials, increase in private insurance and favorable reimbursement scenario. The key market indicators influencing global basal cell carcinoma treatment market taken into consideration including cost constraints and regulatory landscape.

Basal Cell Carcinoma Treatment Market: Scope of the Study

The report provides market size in terms of US$ Mn for each segment for the period from 2015 to 2025, considering the macro and micro environmental factors. Growth rates for each segment within the global basal cell carcinoma treatment market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements. It also includes value chain analysis of the global basal cell carcinoma treatment industry. A pipeline analysis highlighting major pipeline drugs is also included in the report.

Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year. The year on year growth of global basal cell carcinoma treatment market for each segment is also reflected. Additionally, market related factors such as technological advancements, changing environmental factors, and growing disease awareness initiatives and greater affordability for patients in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Basal Cell Carcinoma Treatment Market: Segmentation

Based on treatment type, the global basal cell carcinoma treatment market has been segmented into surgical (surgical excision, electrodessication & cutterage (ED&C), Moh's surgery, and cryosurgery), drugs (topical treatment, advanced medication, and other) and others. Based on end-user, the market has been segmented into hospitals, specialty clinics, and others. Hospitals segment is expected to remain dominant during the forecast period.

Geographically, the global basal cell carcinoma treatment market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented into major countries in each of the regions. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Australia, Japan, Brazil, GCC, South Africa and Mexico.

Basal Cell Carcinoma Treatment Market: Competitive Landscape

The report includes market attractiveness analysis of the major segments that provides a thorough analysis of the overall competitive scenario in the global basal cell carcinoma treatment market. It profiles major players in the basal cell carcinoma treatment market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments.

A thorough market share analysis of major companies operating in the basal cell carcinoma treatment market is provided in the report. Key companies profiled in the report include Sun Pharmaceuticals Ltd., Valeant Pharmaceuticals International, Inc., Mylan N.V., F. Hoffmann-La Roche Ltd., and Merck & Co., Inc.

The global basal cell carcinoma treatment market has been segmented as follows:

By Treatment Type

  • Surgical
    • Surgical Excision
    • Electrodessication & Cutterage (ED&C)
    • Moh's Surgery
    • Cryosurgery
  • Drugs
    • Topical Treatment
    • Advanced Medication
    • Other
  • Others
    • Radiation Therapy
    • Photodynamic Therapy (PDT)
    • Laser Therapy

By End User

  • Hospitals
  • Specialty Clinics
  • Others

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Australia & New Zealand
    • Japan
    • China
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC
    • Rest of Middle East & Africa
Note: Product cover images may vary from those shown
2 of 2
Section 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights

Section 2 Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology

Section 3 Executive Summary
3.1 Global Basal Cell Carcinoma Treatment: Market Snapshot
3.2 Market Share Analysis by Region, 2016
3.3 Market Opportunity Map

Section 4 Market Overview
4.1 Market Overview
4.2 Global Basal Cell Carcinoma Treatment Market: Market Indicators
4.3 Global Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, 2015-2025
4.4 Global Basal Cell Carcinoma Treatment Market: Market Outlook

Section 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.2.1 Changing Environmental Factors
5.2.2 Stringent Regulatory Policies Assuring Better Product Quality
5.2.3 Favorable Reimbursement Scenario
5.2.4 Growing Disease Awareness Initiatives
5.2.5 Rise in Geriatric Population
5.3 Restraints
5.3.1 Lack of Awareness in Developing Countries
5.3.2 High Cost of Treatment
5.4 Opportunities
5.4.1 Emerging Markets in Developing Countries
5.4.2 Alternative Potential Therapies
5.5 Key Trends
5.6 Basal Cell Carcinoma Treatment Market: Value Chain Analysis
5.7 Pipeline Analysis: Basal Cell Carcinoma Market
5.8 Key Success Factors of Top 3 Companies
5.9 Healthcare Overview

Section 6 Basal Cell Carcinoma Treatment Market Analysis, by Treatment
6.1 Introduction
6.2 Global Basal Cell Carcinoma Treatment Market Value Share Analysis, by Treatment
6.3 Basal Cell Carcinoma Treatment Market Forecast, by Treatment
6.3.1 Surgical
6.3.1.1 Surgical Excision
6.3.1.2 Electrodessication & Cutterage (ED&C)
6.3.1.3 Moh's Surgery
6.3.1.4 Cryosurgery
6.3.2 Drugs
6.3.2.1 Topical Treatment
6.3.2.2 Advanced Medication
6.3.2.3 Other
6.3.3 Others
6.3.3.1 Radiation Therapy
6.3.3.2 Photodynamic Therapy (PDT)
6.3.3.3 Laser Therapy
6.4 Market Attractiveness Analysis, by Treatment

Section 7 Basal Cell Carcinoma Treatment Market Analysis, by End User
7.1 Introduction
7.2 Global Basal Cell Carcinoma Treatment Market Value Share Analysis, by End-user
7.3 Basal Cell Carcinoma Treatment Market Forecast, by End-user
7.3.1 Hospitals
7.3.2 Specialty Clinics
7.3.3 Others
7.4Market Attractiveness Analysis, by End-user

Section 8 Basal Cell Carcinoma Treatment Market Analysis, by Region
8.1 Global Basal Cell Carcinoma Treatment Market, Global Market Scenario
8.2 Global Basal Cell Carcinoma Treatment Market Value Share Analysis, by Region
8.3 Basal Cell Carcinoma Treatment Market Forecast, by Region
8.4 Market Attractiveness Analysis, by Region

Section 9 North America Basal Cell Carcinoma Treatment Market Analysis
9.1 Regional Outlook
9.2 Market Overview
9.3 Market Analysis, by Treatment
9.3.1 Market Value Share Analysis, by Treatment
9.3.2 Market Size (US$ Mn) Forecast, by Treatment
9.3.2.1 Surgical
9.3.2.1.1 Surgical Excision
9.3.2.1.2 Electrodessication & Cutterage (ED&C)
9.3.2.1.3 Moh's Surgery
9.3.2.1.4 Cryosurgery
9.3.2.2 Drugs
9.3.2.2.1 Topical Treatment
9.3.2.2.2 Advanced Medication
9.3.2.2.3 Other
9.3.2.3 Others
9.3.2.3.1 Radiation Therapy
9.3.2.3.2 Photodynamic Therapy (PDT)
9.3.2.3.3 Laser Therapy
9.4 Market Analysis, by End-user
9.4.1 Market Value Share Analysis, by End-user
9.4.2 Market Size (US$ Mn) Forecast, by End-user
9.4.2.1 Hospitals
9.4.2.2 Specialty Clinics
9.4.2.3 Others
9.5 Market Analysis, by Country
9.5.1 Market Value Share Analysis, by Country
9.5.2 Market Size (US$ Mn) Forecast, by Country, 2017-2025
9.5.2.1 U.S.
9.5.2.2 Canada
9.6 Market Attractiveness Analysis
9.6.1 by Country
9.6.2 by Treatment
9.6.3 by End-user

Section 10 Europe Basal Cell Carcinoma Treatment Market Analysis
10.1 Regional Outlook
10.2 Market Overview
10.3 Market Analysis, by Treatment
10.3.1 Market Value Share Analysis, by Treatment
10.3.2 Market Size (US$ Mn) Forecast, by Treatment
10.3.2.1 Surgical
10.3.2.1.1 Surgical Excision
10.3.2.1.2 Electrodessication & Cutterage (ED&C)
10.3.2.1.3 Moh's Surgery
10.3.2.1.4 Cryosurgery
10.3.2.2 Drugs
10.3.2.2.1 Topical Treatment
10.3.2.2.2 Advanced Medication
10.3.2.2.3 Other
10.3.2.3 Others
10.3.2.3.1 Radiation Therapy
10.3.2.3.2 Photodynamic Therapy (PDT)
10.3.2.3.3 Laser Therapy
10.4 Market Analysis, by End-user
10.4.1 Market Value Share Analysis, by End-user
10.4.2 Market Size (US$ Mn) Forecast, by End-user
10.4.2.1 Hospitals
10.4.2.2 Specialty Clinics
10.4.2.3 Others
10.5 Market Analysis, by Country
10.5.1 Market Value Share Analysis, by Country
10.5.2 Market Size (US$ Mn) Forecast, by Country, 2017-2025
10.5.2.1 UK
10.5.2.2 Germany
10.5.2.3 France
10.5.2.4 Spain
10.5.2.5 Italy
10.5.2.6 Rest of Europe
10.6 Market Attractiveness Analysis
10.6.1 by Country
10.6.2 by Treatment
10.6.3 by End-user

Section 11 Asia Pacific Basal Cell Carcinoma Treatment Market Analysis
11.1 Regional Outlook
11.2 Market Overview
11.3 Market Analysis, by Treatment
11.3.1 Market Value Share Analysis, by Treatment
11.3.2 Market Size (US$ Mn) Forecast, by Treatment
11.3.2.1 Surgical
11.3.2.1.1 Surgical Excision
11.3.2.1.2 Electrodessication & Cutterage (ED&C)
11.3.2.1.3 Moh's Surgery
11.3.2.1.4 Cryosurgery
11.3.2.2 Drugs
11.3.2.2.1 Topical Treatment
11.3.2.2.2 Advanced Medication
11.3.2.2.3 Other
11.3.2.3 Others
11.3.2.3.1 Radiation Therapy
11.3.2.3.2 Photodynamic Therapy (PDT)
11.3.2.3.3 Laser Therapy
11.4 Market Analysis, by End-user
11.4.1 Market Value Share Analysis, by End-user
11.4.2 Market Size (US$ Mn) Forecast, by End-user
11.4.2.1 Hospitals
11.4.2.2 Specialty Clinics
11.4.2.3 Others
11.5 Market Analysis, by Country
11.5.1 Market Value Share Analysis, by Country
11.5.2 Market Size (US$ Mn) Forecast, by Country, 2017-2025
11.5.2.1 Australia & New Zealand
11.5.2.2 Japan
11.5.2.3 China
11.5.2.4 Rest of APAC
11.6 Market Attractiveness Analysis
11.6.1 by Country
11.6.2 by Treatment
11.6.3 by End-user

Section 12 Latin America Basal Cell Carcinoma Treatment Market Analysis
12.1 Regional Outlook
12.2 Market Overview
12.3 Market Analysis, by Treatment
12.3.1 Market Value Share Analysis, by Treatment
12.3.2 Market Size (US$ Mn) Forecast, by Treatment
12.3.2.1 Surgical
12.3.2.1.1 Surgical Excision
12.3.2.1.2 Electrodessication & Cutterage (ED&C)
12.3.2.1.3 Moh's Surgery
12.3.2.1.4 Cryosurgery
12.3.2.2 Drugs
12.3.2.2.1 Topical Treatment
12.3.2.2.2 Advanced Medication
12.3.2.2.3 Other
12.3.2.3 Others
12.3.2.3.1 Radiation Therapy
12.3.2.3.2 Photodynamic Therapy (PDT)
12.3.2.3.3 Laser Therapy
12.4 Market Analysis, by End-user
12.4.1 Market Value Share Analysis, by End-user
12.4.2 Market Size (US$ Mn) Forecast, by End-user
12.4.2.1 Hospitals
12.4.2.2 Specialty Clinics
12.4.2.3 Others
12.5 Market Analysis, by Country
12.5.1 Market Value Share Analysis, by Country
12.5.2 Market Size (US$ Mn) Forecast, by Country, 2017-2025
12.5.2.1 Brazil
12.5.2.2 Mexico
12.5.2.3 Rest of LATAM
12.6 Market Attractiveness Analysis
12.6.1 by Country
12.6.2 by Treatment
12.6.3 by End-user

Section 13 Middle East & Africa Basal Cell Carcinoma Treatment Market Analysis
13.1 Regional Outlook
13.2 Market Overview
13.3 Market Analysis, by Treatment
13.3.1 Market Value Share Analysis, by Treatment
13.3.2 Market Size (US$ Mn) Forecast, by Treatment
13.3.2.1 Surgical
13.3.2.1.1 Surgical Excision
13.3.2.1.2 Electrodessication & Cutterage (ED&C)
13.3.2.1.3 Moh's Surgery
13.3.2.1.4 Cryosurgery
13.3.2.2 Drugs
13.3.2.2.1 Topical Treatment
13.3.2.2.2 Advanced Medication
13.3.2.2.3 Other
13.3.2.3 Others
13.3.2.3.1 Radiation Therapy
13.3.2.3.2 Photodynamic Therapy (PDT)
13.3.2.3.3 Laser Therapy
13.4 Market Analysis, by End-user
13.4.1 Market Value Share Analysis, by End-user
13.4.2 Market Size (US$ Mn) Forecast, by End-user
13.4.2.1 Hospitals
13.4.2.2 Specialty Clinics
13.4.2.3 Others
13.5 Market Analysis, by Country
13.5.1 Market Value Share Analysis, by Country
13.5.2 Market Size (US$ Mn) Forecast, by Country, 2017-2025
13.5.2.1 South Africa
13.5.2.2 GCC Countries
13.5.2.3 Rest of MEA
13.6 Market Attractiveness Analysis
13.6.1 by Country
13.6.2 by Treatment
13.6.3 by End-user

Section 14 Company Profiles
14.1 Basal Cell Carcinoma Treatment Market Share Analysis, by Company (2016)
14.2 Company Profiles
14.2.1 Sun Pharmaceuticals Ltd.
14.2.1.1 Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2 Financial Overview
14.2.1.3 Product Portfolio
14.2.1.4 SWOT Analysis
14.2.1.5 Strategic Overview
14.2.2 Valeant Pharmaceuticals International, Inc.
14.2.2.1 Company Overview (HQ, Business Segments, Employee Strength)
14.2.2.2 Financial Overview
14.2.2.3 Product Portfolio
14.2.2.4 SWOT Analysis
14.2.2.5 Strategic Overview
14.2.3 Mylan N.V.
14.2.3.1 Company Overview (HQ, Business Segments, Employee Strength)
14.2.3.2 Financial Overview
14.2.3.3 Product Portfolio
14.2.3.4 SWOT Analysis
14.2.3.5 Strategic Overview
14.2.4 F. Hoffmann-La Roche Ltd.
14.2.4.1 Company Overview (HQ, Business Segments, Employee Strength)
14.2.4.2 Financial Overview
14.2.4.3 Product Portfolio
14.2.4.4 SWOT Analysis
14.2.4.5 Strategic Overview
14.2.5 Merck & Co., Inc.
14.2.5.1 Company Overview (HQ, Business Segments, Employee Strength)
14.2.5.2 Financial Overview
14.2.5.3 Product Portfolio
14.2.5.4 SWOT Analysis
14.2.5.5 Strategic Overview
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll